Trial Details
Not RecruitingBasic Information
| Clinical ID | c3268 |
|---|---|
| Identifier | EUCTR2008-004277-17-GB |
| Trial Title | The effectiveness and tolerability of GlobiFer (haem iron) tablets compared to ferrous sulphate tablets in inflammatory bowel disease: a randomised-controlled trial. - Oral haem to treat anaemia in patients with IBD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Anaemia in inflammatory bowel disease;Therapeutic area: Diseases [C] - Symptoms and general pathology [C23] |
| Interventions | Trade Name: Actavis FERROUS SULPHATE TABLETS BP 200mg Product Name: Ferrous sulphate with 65 mg iron++ per tablet Pharmaceutical Form: Tablet INN or Proposed INN: Ferrous sulphate Concentration unit: mg milligram(s) Trade Name: GlobiFer Forte Product Name: GlobiFer Forte Pharmaceutical Form: Tablet INN or Proposed INN: Iron integrated haemolysed haemoglobin powderequal to 18 mg Fe++ Concentration unit: mg milligram(s) Concentration type: equal Concentration unit: mg milligram(s) Concentration type: equal |
Participant Information
| Sponsor | GlobiFer International bvba |
|---|---|
| City | - |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |